Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Sort by

    1. Firms still bending the rules, warns former Enron boss

    2. Former US-based Enron finance chief Andrew Fastow, who served six years' jail for fraud, has told a Singapore audience of his role in one of the biggest corporate scandals in American history. Mr Fastow, 53, speaking pro bono at the Asia-Pacific Fraud Conference last Friday, warned it is the market that will decide if boundary rules have been breached and will show its discomfort through market...

    3. The Swiss National Bank owns millions of shares of Valeant Pharmaceuticals, the controversial drug maker accused of fraud.

    4. Dabhol power plant is a lesson on what to avoid while setting up large infrastructure projects.

    5. Dabhol's assets will be demerged into the power plant and the LNG terminal.

    6. Learn how these must-watch movies for accountants teach about the importance of ethics in a world driven by greed and financial power.

    7. Katherine Soper, winner of the Bruntwood prize, is at the head of a promising group bidding to break down barriers For any British teenage girl hoping to become a playwright, the chances are at last looking rosy. A series of celebrated female dramatists, including creators of hit plays such as Enron , Chimerica and Posh , are now in effect calling out like sirens: “Come on in, the water is ...

    8. Switzerland might be known for making precise clocks, but its timing couldn't be worse on at least one investment.

    9. Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were higher by 6 percent late Monday morning. Notable short-seller Citron Research said that it will not "dial back warnings" on Valeant. ...

    10. 3 Ways Mega-Rich Investors Could Cut Your Drug Prices

      The Fiscal Times via Yahoo! NewsNov 01 03:15 AM

      Shares of Valeant Pharmaceuticals continue to dive after a seething report issued this month by investors betting against the company compared it to Enron and critics questioned its drug-pricing and other business practices. Valeant is just the latest in a string of biotech companies and drug makers to face such high-profile attacks. Since the beginning of the year, investors who bet a stock ...

    1. 12345430 results